|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.51 HKD | 0.00% |
|
-1.92% | -22.73% |
| Apr. 22 | Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug | MT |
| Apr. 17 | Future Data Group Limited Announces Changes to its Board | CI |
Future Data Group Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was HKD 69.24 million compared to HKD 124.35 million a year ago. Net loss was HKD 10.45 million compared to HKD 4.67 million a year ago.
Basic loss per share from continuing operations was HKD 0.0242 compared to HKD 0.0108 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -22.73% | 35.67M | |
| +2.39% | 34.89B | |
| +3.09% | 15.58B | |
| -6.41% | 9.02B | |
| +3.10% | 7.25B | |
| -42.99% | 4.71B | |
| +8.63% | 2.94B | |
| +6.56% | 2.43B | |
| -13.45% | 2.37B | |
| -14.99% | 2.07B |
FUTURE DATA GROUP LIMITED 
